Letter From the President
While the meeting is over, the connections and memories are not. It was great to see all of you at TS23. The weather was great, the science greater and you—greatest. Connecting with you all was wonderful. The visit to Capitol Hill was also terrific, meaningful and so important. Dale Dirks and Dane Christiansen, our advocates, take such a hard job, matching 200 of us with our representatives, and make it look easy. It was truly awesome. I’d like to share the metrics with you. However, the results from the survey are still being compiled. In the meantime, we heard stories of how you enjoyed the meetings, workshops, plenaries, and sessions. I have one simple request—if you are interested in joining an ACTS Committee, please reach out to ACTS and let us know so we can add you to our list of interested members. In the spirit of TS23, we want to thank the Program Committee, the speakers and all of you who participated to make this one of the best meetings I have attended in a long time. We look forward to hearing your ideas for next year and I look forward to working with you one more year. Thanks again for your support of ACTS.
Linda B. Cottler, PhD, MPH, FACE
Lasker Clinical Research Scholars Program
The National Institutes of Health, in partnership with the Lasker Foundation, is pleased to announce the 2023-24 Lasker Clinical Research Scholars Program. The program supports clinical researchers in the early stages of their independent careers. Lasker Scholars are appointed as tenure-track investigators in the NIH Intramural Research Program for 5 years, followed by 3 years of funding at an extramural research institution (up to $500,000 direct costs per year) or continued appointment in the intramural program. Candidates must have a clinical doctoral degree and a professional license to practice in the United States, and cannot already have obtained tenure at a research institution. The application deadline is August 25, 2023.
More information can be obtained at the Lasker Scholar website, or by contacting Dr. Charles Dearolf at LaskerScholar@nih.gov.
44th Annual Meeting of the Society for Clinical Trials
Registration is now open for the 44th Annual Meeting of the Society for Clinical Trials “Championing High-quality Evidence to Optimize Human Health," taking place May 21-24, 2023 in Baltimore, MD.
The Annual Meeting of the Society for Clinical Trials is a multidisciplinary program with broad participation. The meeting brings together the clinical trials community from academia, the pharmaceutical and device industries, government agencies, medical groups and centers and clinical research entities.
More information can be obtained on the event website and the event flyer.
Journal of Clinical and Translational Science: The Official Journal of ACTS and CR Forum
Share innovative advances in the translational science area to the global research community through JCTS!
- Gold Open Access: fully compliant with Open Access Mandates
- Articles funded by the NIH will be manually sent to PubMed Central
- Articles appear with their final citation details as soon as they are published online
- Prestigious editorial board listing
- Global dissemination of your paper
- Metrics, Altmetrics and Kudos to monitor submissions
Want to receive alerts when new articles are published? Click the 'Add Alert' (🔔) icon here, then login or register for a Cambridge Core account to receive daily, weekly, or monthly updates.
Submit Your Research
Do you know someone who deserves to be recognized for outstanding or groundbreaking work? Is your institution embarking on an exciting project? Send ACTS your story to be highlighted in future issues of the ACTS Connection.
Submit stories here.
The ACTS Career Center is the premier resource for connecting those in the field of translational science with career opportunities. Visit today to find a wealth of resources to help achieve your career goals.
ACTS members receive a 50% discount on the site—use code ACTSMEMBER to save!
Translational Science Today
Found in translation - UNC Research
Dr. Carol Feghali-Bostwick and Dr. ReJoyce Green received prestigious awards at this year's Translational Science conference in Washington, D.C.